257 related articles for article (PubMed ID: 32885175)
61. Hydrocortisone does not influence glucocorticoid sensitivity of acute lymphoblastic leukemia cells.
Warris LT; van den Heuvel-Eibrink MM; Ariës IM; Pieters R; van den Akker EL; den Boer ML
Haematologica; 2015 Apr; 100(4):e137-9. PubMed ID: 25425687
[No Abstract] [Full Text] [Related]
62. Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticod resistance in childhood leukemia.
Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
Leukemia; 2004 Mar; 18(3):530-7. PubMed ID: 14724649
[TBL] [Abstract][Full Text] [Related]
63. Genomic and transcriptomic profiles and in vitro resistance to mitoxantrone and idarubicin in pediatric acute leukemias.
Laskowska J; Lewandowska-Bieniek J; Szczepanek J; Styczyński J; Tretyn A
J Gene Med; 2016 Aug; 18(8):165-79. PubMed ID: 27280600
[TBL] [Abstract][Full Text] [Related]
64. Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies.
Zhai Y; Tang Q; Fang DD; Deng J; Zhang K; Wang Q; Yin Y; Fu C; Xue SL; Li N; Zhou F; Yang D
Clin Cancer Res; 2023 Jan; 29(1):183-196. PubMed ID: 36240005
[TBL] [Abstract][Full Text] [Related]
65. [Association between BIM gene and glucocorticoid resistance in children with acute lymphoblastic leukemia].
Xu JY; Luo JM
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Aug; 19(8):945-949. PubMed ID: 28774373
[TBL] [Abstract][Full Text] [Related]
66. Altered expression of autophagy-related genes might contribute to glucocorticoid resistance in precursor B-cell-type acute lymphoblastic leukemia.
Sarang Z; Gyurina K; Scholtz B; Kiss C; Szegedi I
Eur J Haematol; 2016 Nov; 97(5):453-460. PubMed ID: 26947147
[TBL] [Abstract][Full Text] [Related]
67. Quantitative analysis and modeling of glucocorticoid-controlled gene expression.
Chen DW; Lynch JT; Demonacos C; Krstic-Demonacos M; Schwartz JM
Pharmacogenomics; 2010 Nov; 11(11):1545-60. PubMed ID: 21121775
[TBL] [Abstract][Full Text] [Related]
68. Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.
Tamai M; Kasai S; Akahane K; Thu TN; Kagami K; Komatsu C; Abe M; Watanabe A; Goi K; Miyake K; Inaba T; Takita J; Goto H; Minegishi M; Iwamoto S; Sugita K; Inukai T
J Steroid Biochem Mol Biol; 2022 Apr; 218():106068. PubMed ID: 35124168
[TBL] [Abstract][Full Text] [Related]
69. Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia.
Hulleman E; Broekhuis MJ; Pieters R; Den Boer ML
Haematologica; 2009 Sep; 94(9):1322-4. PubMed ID: 19734428
[No Abstract] [Full Text] [Related]
70. Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia.
Yan J; Jiang N; Huang G; Tay JL; Lin B; Bi C; Koh GS; Li Z; Tan J; Chung TH; Lu Y; Ariffin H; Kham SK; Yeoh AE; Chng WJ
Br J Haematol; 2013 Oct; 163(1):93-103. PubMed ID: 23888996
[TBL] [Abstract][Full Text] [Related]
71. In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile.
Sorich MJ; Pottier N; Pei D; Yang W; Kager L; Stocco G; Cheng C; Panetta JC; Pui CH; Relling MV; Cheok MH; Evans WE
PLoS Med; 2008 Apr; 5(4):e83. PubMed ID: 18416598
[TBL] [Abstract][Full Text] [Related]
72. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
[TBL] [Abstract][Full Text] [Related]
73. Thioimidazoline based compounds reverse glucocorticoid resistance in human acute lymphoblastic leukemia xenografts.
Toscan CE; Rahimi M; Bhadbhade M; Pickford R; McAlpine SR; Lock RB
Org Biomol Chem; 2015 Jun; 13(22):6299-312. PubMed ID: 25967739
[TBL] [Abstract][Full Text] [Related]
74. Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia.
Marke R; Havinga J; Cloos J; Demkes M; Poelmans G; Yuniati L; van Ingen Schenau D; Sonneveld E; Waanders E; Pieters R; Kuiper RP; Hoogerbrugge PM; Kaspers GJ; van Leeuwen FN; Scheijen B
Leukemia; 2016 Jul; 30(7):1599-603. PubMed ID: 26713593
[No Abstract] [Full Text] [Related]
75. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
[TBL] [Abstract][Full Text] [Related]
76. Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia.
Pui CH
Front Med; 2015 Mar; 9(1):1-9. PubMed ID: 25511622
[TBL] [Abstract][Full Text] [Related]
77. Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia.
Rainer J; Ploner C; Jesacher S; Ploner A; Eduardoff M; Mansha M; Wasim M; Panzer-Grümayer R; Trajanoski Z; Niederegger H; Kofler R
Leukemia; 2009 Apr; 23(4):746-52. PubMed ID: 19148136
[TBL] [Abstract][Full Text] [Related]
78. Role of microRNAs in glucocorticoid‑resistant B‑cell precursor acute lymphoblastic leukemia.
Sakurai N; Komada Y; Hanaki R; Morimoto M; Ito T; Nakato D; Hirayama M
Oncol Rep; 2019 Aug; 42(2):708-716. PubMed ID: 31233193
[TBL] [Abstract][Full Text] [Related]
79. Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia.
Shi Y; Beckett MC; Blair HJ; Tirtakusuma R; Nakjang S; Enshaei A; Halsey C; Vormoor J; Heidenreich O; Krippner-Heidenreich A; van Delft FW
Haematologica; 2021 Apr; 106(4):1056-1066. PubMed ID: 32139432
[TBL] [Abstract][Full Text] [Related]
80. Involvement of miR17 pathway in glucocorticoid-induced cell death in pediatric acute lymphoblastic leukemia.
Harada M; Pokrovskaja-Tamm K; Söderhäll S; Heyman M; Grander D; Corcoran M
Leuk Lymphoma; 2012 Oct; 53(10):2041-50. PubMed ID: 22475310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
